[Congressional Bills 117th Congress]
[From the U.S. Government Publishing Office]
[S. 3394 Introduced in Senate (IS)]
<DOC>
117th CONGRESS
1st Session
S. 3394
To amend the Federal Food, Drug, and Cosmetic Act with respect to
emergency use authorization transparency.
_______________________________________________________________________
IN THE SENATE OF THE UNITED STATES
December 14, 2021
Ms. Hassan (for herself, Mr. Braun, and Ms. Murkowski) introduced the
following bill; which was read twice and referred to the Committee on
Health, Education, Labor, and Pensions
_______________________________________________________________________
A BILL
To amend the Federal Food, Drug, and Cosmetic Act with respect to
emergency use authorization transparency.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Emergency Use Transparency Act''.
SEC. 2. INCREASING EUA TRANSPARENCY.
Section 564(h)(1) of the Federal Food, Drug, and Cosmetic Act (21
U.S.C. 360bbb-3(h)(1)) is amended--
(1) by inserting ``on the internet website of the Food and
Drug Administration and'' after ``promptly publish''; and
(2) by striking ``application under section 505(i) 512(j),
or 520(g), even if such summary may indirectly reveal the
existence of such application'' and inserting ``application,
request, or submission under this section or section 505(b),
505(i), 505(j), 512(b), 512(j), 512(n), 515, 510(k), 513(f)(2),
520m(g), 520(m), 571, or 572 of this Act, or section 351(a) or
351(k) of the Public Health Service Act, even if such summary
may reveal the existence of such an application, request, or
submission, or data contained in such application, request, or
submission''.
<all>